Today's Information

Provided by: TaiMed Biologics Inc.
SEQ_NO 1 Date of announcement 2022/03/11 Time of announcement 16:45:04
Subject 
 The Company's Board of Directors resolved to
convene the 2022 Annual Shareholders' Meeting
Date of events 2022/03/11 To which item it meets paragraph 17
Statement 
1.Date of the board of directors resolution:2022/03/11
2.General shareholders' meeting date:2022/05/30
3.General shareholders' meeting location:3F, Dazhi, Denwell
 (3F., No.8, Zhifu Rd., Zhongshan Dist., Taipei Taiwan)
4.Shareholders meeting will be held by means of (physical shareholders
 meeting/ visual communication assisted shareholders meeting /
 visual communication shareholders meeting):
physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)2021 business report and the implementation report for the sound
   operating plan.
(2)2021 audit committee's review report.
(3)Report on the amendment to"Corporate Social Responsibility Best
   Practice Principles"
6.Cause for convening the meeting II.Acknowledged matters:
(1)Adoption of 2021 business report and financial statements.
(2)Adoption of the Proposal for 2021 Deficit Compensation.
7.Cause for convening the meeting III.Matters for Discussion:
(1)Amendment to the Company Corporate Charter (Articles of Incorporation)
   (Proposed by the Board of Directors)
(2)Amendment to the Operational procedures for Acquisition and Disposal of
   Assets (Proposed by the Board of Directors)
(3)On the lifting of non-competition restrictions for Directors.(Proposed by
   the Board of Directors)
8.Cause for convening the meeting IV.Election matters:
 Re-election of all Board Directors
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/04/01
12.Book closure ending date:2022/05/30
13.Any other matters that need to be specified:
Pursuant to Article 172-1 of the Company Act, the Company will accept
shareholders' proposals or directors' nominations. Shareholders holding more
than one percent (1%) of the Company's total issued shares may submit
proposals to the Company (Address: 3F, No.607,Ruiguang Rd., Neihu District,
Taipei 114, Taiwan) in written form during the period from 2022/03/21 to
2022/03/31.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

TaiMed Biologics Inc. published this content on 11 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2022 08:55:00 UTC.